Medican Enterprises Inc. (MDCN), announced today that the 67,000 square foot facility located, in Phoenix Arizona, it is acquiring has received zoning approval and is now zone compliant for the operation of legal #$%$ businesses.
“With the zoning approval in hand, this commercial transaction now meets our criteria and we are moving rapidly to finalize the due diligence process,” commented Ken Williams, CEO of Medican Enterprises. “Located just minutes from Hwy 60 and the I-17 and featuring excellent visibility in a high traffic center, this unique property represents the type of asset we are looking for.”
The transaction is planned for closure by the end of the first quarter of 2015.
Amarantus to Present Positive Alzheimer's Disease Biomarker Data on the LymPro Test(R) at the 12th International Conference on Alzheimer's and Parkinson's Diseases and Related Neurological Disorders
SAN FRANCISCO and GENEVA, Feb. 23, 2015 (GLOBE NEWSWIRE) -- Amarantus BioSciences Holdings, Inc. (OTCQB:AMBS), a biotechnology company focused on developing diagnostics in neurology, and therapeutic products with the potential for orphan drug designation in the areas of neurology, psychiatry, ophthalmology and regenerative medicine, announced that its abstract titled, "The LymPro® Assay: A Biomarker For Alzheimer's Disease Using Blood Samples From Clinically Diagnosed Alzheimer's Disease And Cognitively Intact Subjects," was accepted for poster presentation at the 12th International Conference on Alzheimer's and Parkinson's Diseases and Related Neurological Disorders (AD/PDTM 2015) being held March 18-22, 2015, in Nice, France.
The poster will highlight the positive data analysis of whole blood samples from 140 subjects (71 Alzheimer's disease and 69 age matched controls) using the company's LymPro Test blood-based assay for Alzheimer's disease (AD). The LymPro Test measures lymphocyte proliferation in response to a mitogenic stimulus and quantifies the extent to which lymphocytes have entered the cell division cycle. Cell cycle dysregulation in neurons is a key pathology in AD, that results in neuronal death and cognitive decline. In the LymPro test, lymphocyte measurements are used as a surrogate for this neuronal cell dysfunction. The analysis demonstrates that, in combination with standard of care clinical measurements, LymPro can give physicians greater confidence that an Alzheimer's diagnosis is truly accurate.
"We are very pleased to have this confirmatory LymPro abstract accepted for a poster session at one of the premiere scientific congresses focused on neurological disorders," said Gerald E. Commissiong, President & CEO of Amarantus BioSciences Holdings, Inc. "We believe the LymPro Test is an important leading Alzheimer's biomarker assay and is a key diagnostic asset for advancing robust therapeutic clinical studies in Alzheimer's disease. This conference will provide important exposure as we continue building a significant customer base for blood-based biomarker services in Alzheimer's disease, with the ultimate shared goal of improving the current standard of care used to treat AD."
The poster data to be presented at AD/PD 2015 by Louis Kirby, Corporate Advisor and Medical Director of Amarantus Diagnostics, confirms the consistent and accurate ability of the LymPro Test to distinguish univariate and multivariate combination indicators of lymphocyte proliferation AD biomarkers from controls. Additionally, the analysis corroborates two previous peer-reviewed publications in which data from the Company's recently completed LP-002 clinical study established the LymPro Test as an advantageous diagnostic that can serve as the first step in a multistep diagnostic process for early identification of Alzheimer's disease.
Sentiment: Strong Buy
I will check them out, st is stock twits. I f I like a stock I will go on there and check out some of the commentary....it is still picking and choosing however. Some individuals are worht following. I was invested in a bio tech, followed the company on Stock Twits and managed to block over 7 pages worth of folks! LOL! I will continue to delve into all the leads you gave me. As I said before, I still have some time to decide. Thank you for all your help. I'll check ya out on twtr. Nick
William, do you mind if I pick your brain one more time? What are your viewpoints both negative and positive for $OIL? Seems to be in a good position for investment purposes.Also if you are on twtr or ST let me know. I would follow ya. Have a great day! Many thanks!
This might seem to be a foolish question but here goes....Ticker symbols INT, TSO,WNR. No contango,just stocks??? They all seem to be doing well. Why?? Thanks for your help.
P.S. Just did some research on contango. Had no idea about that.
I understand , as for myself I am long. I believe eventually this will turn around and I agree...I want to be invested it and not miss the boat. Enjoy the rest of the weekend, we are getting 4/6 more inches of snow as we speak!
Thank you very much for the explanation and knowledge on the subject. I just started to invest in USO just a couple of hundred shares, We had an ETF/ PRPFX in our joint account( wife and I) since 2010. Did well with it, and now I have been looking at USO. To me it looks like a good entry point, however the comments that I have been hearing are "still be cautious" and wait for an entry. I do have time so we are in no hurry. I would however like to get in as close to the bottom as possible in order to have a long term investment and continue to invest in USO ion a monthly basis. Wish you the very best! nick
What effect... both negative and positive.... does this have on the price of USO? Sane answers please. Have a great weekend....... U.S. refinery strike widens to include nation's largest refinery
REUTERS — 2:03 AM ET 02/21/15
By Erwin Seba
HOUSTON (Reuters) - The U.S. refinery strike widened as workers at the nation's largest refinery walked off their jobs at 12 a.m. CST (0600 GMT) on Saturday, according to the United Steelworkers union (USW).
Shortly after talks between union and oil company representatives ended on Friday night, the union notified Motiva Enterprises [MOTIV.UL] of a strike by its members at the company's 600,250 barrel per day (bpd) refinery in Port Arthur, Texas.
The USW also gave notices on Friday of strikes to begin in 24 hours at Motiva's 235,000 bpd Convent, Louisiana and 238,000 bpd Norco, Louisiana refineries and the Shell Oil Co chemical plant in Norco, the union said.
"The industry’s refusal to meaningfully address safety issues through good faith bargaining gave us no other option but to expand our work stoppage," USW International President Leo Gerard said in a statement.
Motiva is a 50-50 joint venture of Royal Dutch Shell Plc and Saudi Aramco [SDABO.UL]. Shell's U.S. arm Shell Oil Co is the lead oil company negotiator in talks with the USW for a national agreement on safety, pay and benefits.
A Shell spokesman said the company was disappointed by the Port Arthur walkout and strike notices to the Louisiana plants.
"We believe this move sets the wrong tone for both parties to move forward and reach an agreement," said Shell spokesman Ray Fisher. "We remain committed to continued safe operations and productive negotiations."
If no agreement is reached between Shell and the USW by early Sunday morning, a total of 6,550 workers at 15 plants, including 12 refineries accounting for 18.5 percent of U.S. production capacity, will be walking picket lines in the largest national refinery strike since 1980.
This is the first expansion of the strike since Feb. 6, when workers at BP Plc-operated refineries in Indiana and Ohio were told to begin a work stoppage the following day.
Workers are already on strike at Shell's 327,000 bpd joint-venture refinery in Deer Park, Texas, and an adjoining chemical plant. The Deer Park workforce walked out when the strike began on Feb. 1.
The strike may complicate operations at the Port Arthur refinery, which failed to restore its second largest crude distillation unit (CDU) to full production after restarting on Friday following a three-day shutdown to fix leaking piping, sources told Reuters.
The 195,000 bpd CDU is one of three at the refinery that do the initial refining of crude oil coming into the plant and provide feedstock for all other production units.
The refinery's largest CDU, which has a rated capacity of 325,000 bpd is running at about 200,000 bpd, the sources said, because a 60,000 bpd hydrocracking unit is shut due to a malfunction. The hydrocracker produces motor fuel, primarily diesel, which has become a lucrative export for U.S. refiners.
Motiva is also overhauling the 92,000 bpd gasoline-producing fluidic catalytic cracking unit at the refinery. It is scheduled to restart in the first half of March. It was shut in early January.
Shell and the union have been meeting continuously since talks resumed on Wednesday following a week-long break for the company to reply to an information request and a counterproposal from the USW.
Union negotiators rejected the seventh contract offer from Shell on Thursday night.
Earlier this week, the USW's lead negotiator, International Vice President Gary Beevers, told Reuters that safe staffing levels at refineries and chemical plants were a sticking point in the talks.
Another sticking point is the absence of no-retrogression language, which preserves agreements from previous contracts not addressed in negotiations this year.
In addition to the two BP-operated plants, workers are striking at refineries and plants owned by Lyondell Basell, Marathon Petroleum Corp, and Tesoro Corp in California, Kentucky, Texas and Washington state.
Only one refinery has shut down due to the strike.
Tesoro's 166,000-bpd plant in Martinez, California, was scheduled prior to the strike for a partial shutdown to perform a planned multi-unit overhaul. Company officials decided to idle the entire plant after the walkout began and said production would not resume during the work stoppage.
The USW is seeking a three-year, industrywide pact that would cover 30,000 workers at 63 U.S. refineries that together account for two-thirds of domestic capacity.
Companies have called on temporary replacement workers to keep plants running at nearly normal levels.
Listen, if you can't take his word then it is not a long term investment."John Loren was on StockRadio YESTERDAY suggesting the close was today and also suggested the closing would bring $3.9MM in revenue to MDCN". That is what he said right? I am a strong buy up until 4 p.m. today.
Sentiment: Strong Buy
Let's see what happens today. We will have our answer by 4 p.m. EST. Have a great day. If ya want some body to follow on twit... BTW, moon_shine15. is right on the $ most of the time....if ya want some quick day trades or swing.trades. Check him out. He gave me this a few months back. Did my DD and I liked it
Sentiment: Strong Buy